Adaptive designs are thought to be the new paradigm in drug development, allowing statisticians and trial designers to create trials that give the best probability of success for each drug, while diminishing clinical development costs. Over the next weeks we'll be releasing 2-3 infographics on adaptive trials and clinical development.
Old and New Drug Development Paradigms
This infographic demonstrates three critical differences between old and new drug development paradigms: the budget allocations, the decision-making oportunities, and the resulting decrease in the length of a highly powered trial.
For more information read:
- To Adapt or Not to Adapt: 10 Simple Steps to Deciding Whether Your Next Trial Should be Adaptive
- Adaptive Clinical Trials: Your Questions Answered
